RZLT net incomeQ1 2027-$18.49M
RZLT net income was -$18.49M in fiscal Q1 2027 (ended Sep 30, 2026), compared with -$18.15M a year earlier. For the full fiscal 2026 it was -$77.59M, compared with -$74.41M in fiscal 2025.
For the twelve months ended Sep 30, 2026, Rezolute Inc. reported -$77.92M of net income.
RZLT net income was -$18.49M in fiscal Q1 2027 (ended Sep 30, 2026), compared with -$18.15M a year earlier. For the full fiscal 2026 it was -$77.59M, compared with -$74.41M in fiscal 2025.
RZLT diluted EPS was -$0.18 in fiscal Q1 2027 (ended Sep 30, 2026), compared with -$0.18 a year earlier. For the full fiscal 2026 it was -$0.75, compared with -$0.98 in fiscal 2025.
| Line item | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | Jun 30, 2019 | Jun 30, 2018 | Jun 30, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | $53.80M | $61.53M | $55.74M | $43.81M | $32.49M | $14.99M | $14.45M | $19.08M | $17.28M | $12.09M |
| Selling, general and admin | $29.17M | $18.37M | $14.68M | $12.18M | $9.36M | $7.91M | $6.07M | $6.87M | $9.10M | $8.23M |
| Operating income | -$82.97M | -$79.89M | -$70.42M | -$55.99M | -$41.84M | -$22.89M | -$20.52M | -$25.94M | -$28.73M | -$20.32M |
| Interest expense | - | - | - | - | - | $375.0K | $0 | $4.96M | $689.0K | $1.6K |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$77.59M | -$74.41M | -$68.46M | -$51.79M | -$41.06M | -$20.90M | -$20.33M | -$30.45M | -$29.86M | -$20.28M |
| EPS, basic | -$0.75 | -$0.98 | -$1.33 | -$1.01 | -$2.26 | -$2.72 | -$3.54 | -$18.41 | -$27.00 | -$28.50 |
| EPS, diluted | -$0.75 | -$0.98 | -$1.33 | -$1.01 | -$2.32 | -$2.72 | -$3.54 | -$18.41 | -$27.00 | -$28.50 |
| Diluted shares | 103.9M | 76.0M | 51.5M | 51.2M | 19.5M | 7.7M | 5,751 | 1,777 | 1,113.1 | 825,934.82 |
| Line item | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | Jun 30, 2019 | Jun 30, 2018 | Jun 30, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $10.62M | $94.11M | $70.40M | $16.04M | $150.41M | $41.05M | $9.96M | $37.60M | $11.57M | $4.49M |
| Short-term investments | $97.19M | $73.75M | $56.48M | $85.86M | - | - | - | - | - | - |
| Current assets | $110.51M | $171.15M | $128.65M | $104.91M | $152.10M | $41.99M | $10.52M | $12.14M | $2.01M | $4.93M |
| Total assets | $112.85M | $175.49M | $132.74M | $123.72M | $152.42M | $42.61M | $10.96M | $12.25M | $2.50M | $10.63M |
| Current liabilities | $11.42M | $11.91M | $9.61M | $5.20M | $2.46M | $1.97M | $3.23M | $8.38M | $6.25M | $1.77M |
| Long-term debt | - | - | - | - | - | - | - | - | $0 | - |
| Total debt | - | - | - | - | - | $13.97M | $0 | $0 | $0 | - |
| Total liabilities | $12.16M | $13.36M | $11.73M | $7.55M | $2.95M | $16.51M | $3.60M | $10.50M | $6.46M | $2.10M |
| Shareholders' equity | $100.69M | $162.13M | $121.00M | $116.17M | $149.47M | $26.10M | $7.37M | $1.75M | -$3.96M | $8.53M |
| Line item | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | Jun 30, 2019 | Jun 30, 2018 | Jun 30, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$64.64M | -$69.08M | -$57.37M | -$44.48M | -$39.62M | -$20.44M | -$24.17M | -$15.30M | -$14.11M | -$13.31M |
| Capital expenditures | - | - | - | $153.0K | - | - | $0 | $47.0K | $6.0K | - |
| Free cash flow | - | - | - | -$44.63M | - | - | -$24.17M | -$15.35M | -$14.12M | - |
| Investing cash flow | -$21.10M | -$14.54M | $48.70M | -$101.46M | - | $0 | $0 | $231.0K | $1.73M | -$195.4K |
| Financing cash flow | $2.24M | $107.33M | $63.03M | $11.57M | $148.98M | $51.53M | $22.55M | $25.00M | $9.54M | $13.93M |
| Share repurchases | - | - | $3.0K | - | - | - | - | - | - | - |
| Stock-based compensation | $14.46M | $7.12M | $7.36M | $7.27M | $3.69M | $3.96M | $3.32M | $2.64M | $5.09M | $6.01M |
| Depreciation and amortization | $31.0K | $31.0K | $36.0K | $30.0K | $13.0K | $13.0K | $18.0K | $49.0K | $1.07M | - |
| Line item | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | Jun 30, 2019 | Jun 30, 2018 | Jun 30, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on equity | -77.1% | -45.9% | -56.6% | -44.6% | -27.5% | -80.1% | -276.1% | -1737.8% | - | -237.8% |
| Return on assets | -68.8% | -42.4% | -51.6% | -41.9% | -26.9% | -49.1% | -185.4% | -248.5% | -1193.0% | -190.8% |
| Current ratio | 9.68 | 14.37 | 13.39 | 20.18 | 61.78 | 21.34 | 3.26 | 1.45 | 0.32 | 2.78 |
| Debt to equity | - | - | - | - | - | 0.54 | 0.00 | 0.00 | - | - |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | $12.81M | $14.89M | $11.41M | $14.35M | $13.15M | $20.86M | $15.28M | $12.63M | $12.75M | $19.09M | $12.40M | $12.04M |
| Selling, general and admin | $6.58M | $6.67M | $5.95M | $9.87M | $6.67M | $4.99M | $4.74M | $4.45M | $4.19M | $4.01M | $3.81M | $3.15M |
| Operating income | -$19.39M | -$21.56M | -$17.37M | -$24.22M | -$19.82M | -$25.85M | -$20.02M | -$17.08M | -$16.94M | -$23.10M | -$16.21M | -$15.19M |
| Net income | -$18.49M | -$20.49M | -$16.17M | -$22.77M | -$18.15M | -$24.39M | -$18.91M | -$15.73M | -$15.38M | -$22.98M | -$17.05M | -$13.91M |
| EPS, basic | -$0.18 | -$0.19 | -$0.16 | -$0.22 | -$0.18 | -$0.27 | -$0.27 | -$0.22 | -$0.22 | -$0.44 | -$0.34 | -$0.27 |
| EPS, diluted | -$0.18 | -$0.19 | -$0.16 | -$0.22 | -$0.18 | -$0.27 | -$0.27 | -$0.22 | -$0.22 | -$0.44 | -$0.34 | -$0.27 |
| Diluted shares | 104.8M | - | 104.0M | 103.7M | 103.4M | - | 70.0M | 69.9M | 69.7M | - | 50.8M | 51.4M |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $8.15M | $10.62M | $11.24M | $11.94M | $9.10M | $94.11M | $14.60M | $8.93M | $10.47M | $70.40M | $5.93M | $12.50M |
| Short-term investments | $81.85M | $97.19M | $109.03M | $120.99M | $143.10M | $73.75M | $72.30M | $87.61M | $97.80M | $56.48M | $74.09M | $80.09M |
| Current assets | $93.83M | $110.51M | $122.05M | $135.11M | $154.71M | $171.15M | $88.73M | $98.69M | $110.18M | $128.65M | $82.21M | $96.08M |
| Total assets | $96.01M | $112.85M | $125.46M | $138.63M | $158.66M | $175.49M | $94.74M | $112.01M | $123.41M | $132.74M | $87.74M | $102.15M |
| Current liabilities | $9.46M | $11.42M | $7.70M | $9.53M | $10.21M | $11.91M | $10.53M | $10.61M | $7.99M | $9.61M | $6.96M | $8.01M |
| Total liabilities | $10.06M | $12.16M | $8.63M | $10.63M | $11.50M | $13.36M | $12.17M | $12.42M | $9.97M | $11.73M | $16.88M | $10.42M |
| Shareholders' equity | $85.95M | $100.69M | $116.83M | $128.00M | $147.17M | $162.13M | $82.57M | $99.59M | $113.44M | $121.00M | $70.86M | $91.73M |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$18.78M | -$13.15M | -$13.73M | -$20.32M | -$17.43M | -$22.00M | -$17.40M | -$13.67M | -$16.01M | -$18.52M | -$15.24M | -$13.02M |
| Investing cash flow | $15.77M | $12.30M | $12.28M | $22.81M | -$68.49M | $346.0K | $23.05M | $11.47M | -$49.41M | $19.66M | $8.67M | $17.76M |
| Financing cash flow | $552.0K | $227.0K | $747.0K | $356.0K | $911.0K | $101.16M | $10.0K | $657.0K | $5.50M | $63.33M | -$3.0K | - |
| Share repurchases | - | - | - | - | - | - | - | - | - | $0 | - | - |
| Stock-based compensation | $3.27M | $4.10M | $4.42M | $3.41M | $2.53M | $2.37M | $1.91M | $1.45M | $1.40M | $1.77M | $1.90M | $1.84M |
| Depreciation and amortization | $8.0K | $8.0K | $8.0K | $7.0K | $8.0K | $8.0K | $7.0K | $8.0K | $8.0K | $7.0K | $9.0K | $10.0K |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current ratio | 9.92 | 9.68 | 15.84 | 14.18 | 15.15 | 14.37 | 8.43 | 9.30 | 13.79 | 13.39 | 11.82 | 12.00 |
Source: XBRL data Rezolute Inc. files with the SEC, latest filing dated Nov 5, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures and share counts are restated for stock splits the filings show: 1-for-50, first reported Oct 13, 2020.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| RZLT | - | - | -$77.92M | - | $374.3M |
| LLY | $86.46B | +45.5% | $27.58B | 31.9% | $1.33T |
| JNJ | $99.33B | +7.8% | $16.09B | 16.2% | $679.13B |
| ABBV | $66.01B | +10.7% | $10.34B | 15.7% | $518.44B |
| MRK | $67.38B | +4.9% | $2.45B | 3.6% | $366.73B |
| NVS | $54.53B | +8.4% | $13.98B | 25.6% | $312.35B |
| AZN | $58.74B | +8.6% | $10.22B | 17.4% | $293.69B |
| ABT | $48.23B | +10.0% | $4.70B | 9.7% | $191.40B |
| NVO | DKK 309.06B | +6.4% | DKK 102.43B | 33.1% | $183.23B |